1
|
Howell N, Middleton RJ, Sierro F, Fraser BH, Wyatt NA, Chacon A, Bambery KR, Livio E, Dobie C, Bevitt JJ, Davies J, Dosseto A, Franklin DR, Garbe U, Guatelli S, Hirayama R, Matsufuji N, Mohammadi A, Mutimer K, Rendina LM, Rosenfeld AB, Safavi-Naeini M. Neutron Capture Enhances Dose and Reduces Cancer Cell Viability in and out of Beam During Helium and Carbon Ion Therapy. Int J Radiat Oncol Biol Phys 2024; 120:229-242. [PMID: 38479560 DOI: 10.1016/j.ijrobp.2024.02.052] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/07/2023] [Revised: 02/10/2024] [Accepted: 02/24/2024] [Indexed: 04/14/2024]
Abstract
PURPOSE Neutron capture enhanced particle therapy (NCEPT) is a proposed augmentation of charged particle therapy that exploits thermal neutrons generated internally, within the treatment volume via nuclear fragmentation, to deliver a biochemically targeted radiation dose to cancer cells. This work is the first experimental demonstration of NCEPT, performed using both carbon and helium ion beams with 2 different targeted neutron capture agents (NCAs). METHODS AND MATERIALS Human glioblastoma cells (T98G) were irradiated by carbon and helium ion beams in the presence of NCAs [10B]-BPA and [157Gd]-DOTA-TPP. Cells were positioned within a polymethyl methacrylate phantom either laterally adjacent to or within a 100 × 100 × 60 mm spread out Bragg peak (SOBP). The effect of NCAs and location relative to the SOBP on the cells was measured by cell growth and survival assays in 6 independent experiments. Neutron fluence within the phantom was characterized by quantifying the neutron activation of gold foil. RESULTS Cells placed inside the treatment volume reached 10% survival by 2 Gy of carbon or 2 to 3 Gy of helium in the presence of NCAs compared with 5 Gy of carbon and 7 Gy of helium with no NCA. Cells placed adjacent to the treatment volume showed a dose-dependent decrease in cell growth when treated with NCAs, reaching 10% survival by 6 Gy of carbon or helium (to the treatment volume), compared with no detectable effect on cells without NCA. The mean thermal neutron fluence at the center of the SOBP was approximately 2.2 × 109 n/cm2/Gy (relative biological effectiveness) for the carbon beam and 5.8 × 109 n/cm2/Gy (relative biological effectiveness) for the helium beam and gradually decreased in all directions. CONCLUSIONS The addition of NCAs to cancer cells during carbon and helium beam irradiation has a measurable effect on cell survival and growth in vitro. Through the capture of internally generated neutrons, NCEPT introduces the concept of a biochemically targeted radiation dose to charged particle therapy. NCEPT enables the established pharmaceuticals and concepts of neutron capture therapy to be applied to a wider range of deeply situated and diffuse tumors, by targeting this dose to microinfiltrates and cells outside of defined treatment regions. These results also demonstrate the potential for NCEPT to provide an increased dose to tumor tissue within the treatment volume, with a reduction in radiation doses to off-target tissue.
Collapse
Affiliation(s)
- Nicholas Howell
- Australian Nuclear Science and Technology Organisation, Lucas Heights, Australia
| | - Ryan J Middleton
- Australian Nuclear Science and Technology Organisation, Lucas Heights, Australia
| | - Frederic Sierro
- Australian Nuclear Science and Technology Organisation, Lucas Heights, Australia
| | - Benjamin H Fraser
- Australian Nuclear Science and Technology Organisation, Lucas Heights, Australia
| | - Naomi A Wyatt
- Australian Nuclear Science and Technology Organisation, Lucas Heights, Australia
| | - Andrew Chacon
- Australian Nuclear Science and Technology Organisation, Lucas Heights, Australia
| | - Keith R Bambery
- Australian Nuclear Science and Technology Organisation, Lucas Heights, Australia
| | - Elle Livio
- Australian Nuclear Science and Technology Organisation, Lucas Heights, Australia
| | - Christopher Dobie
- Australian Nuclear Science and Technology Organisation, Lucas Heights, Australia
| | - Joseph J Bevitt
- Australian Nuclear Science and Technology Organisation, Lucas Heights, Australia
| | - Justin Davies
- Australian Nuclear Science and Technology Organisation, Lucas Heights, Australia
| | - Anthony Dosseto
- Wollongong Isotope Geochronology Laboratory, School of Earth, Atmospheric and Life Sciences, University of Wollongong, Wollongong, Australia
| | - Daniel R Franklin
- School of Electrical and Data Engineering, University of Technology Sydney, Ultimo, Australia
| | - Ulf Garbe
- Australian Nuclear Science and Technology Organisation, Lucas Heights, Australia
| | - Susanna Guatelli
- Centre for Medical Radiation Physics, University of Wollongong, Wollongong, Australia
| | - Ryoichi Hirayama
- National Institutes for Quantum Sciences and Technology, Chiba, Japan
| | | | - Akram Mohammadi
- National Institutes for Quantum Sciences and Technology, Chiba, Japan
| | - Karl Mutimer
- Australian Nuclear Science and Technology Organisation, Lucas Heights, Australia
| | - Louis M Rendina
- School of Chemistry, The University of Sydney, Sydney, Australia; The University of Sydney Nano Institute, Sydney, Australia
| | - Anatoly B Rosenfeld
- Centre for Medical Radiation Physics, University of Wollongong, Wollongong, Australia
| | - Mitra Safavi-Naeini
- Australian Nuclear Science and Technology Organisation, Lucas Heights, Australia; Centre for Medical Radiation Physics, University of Wollongong, Wollongong, Australia.
| |
Collapse
|
2
|
Hall AJ, Robertson AG, Baker RW, Hill LR, Rendina LM. Significant cell uptake of Gd(III)-diphenylphosphoryl-diphenylphosphonium complexes: evidence for a new conformationally-dependent tumour cell targeting vector. Chem Commun (Camb) 2023; 59:12511-12514. [PMID: 37789720 DOI: 10.1039/d3cc02706f] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/05/2023]
Abstract
The synthesis, characterisation, and tumour cell uptake of six novel Gd(III)-diphenylphosphoryl-diphenylphosphonium complexes are reported. The propyl-linked Gd(III) complexes can accumulate inside human glioma cells at prodigious levels, approaching 1200%, over the parent triphenylphosphonium salts. DFT and quantum chemical topology analyses support a new type of conformationally-dependent tumour cell targeting vector.
Collapse
Affiliation(s)
- Andrew J Hall
- School of Chemistry, The University of Sydney, Sydney, NSW 2006, Australia.
| | - Amy G Robertson
- School of Chemistry, The University of Sydney, Sydney, NSW 2006, Australia.
| | - Robert W Baker
- School of Chemistry, The University of Sydney, Sydney, NSW 2006, Australia.
| | - Leila R Hill
- School of Chemistry, The University of Sydney, Sydney, NSW 2006, Australia.
| | - Louis M Rendina
- School of Chemistry, The University of Sydney, Sydney, NSW 2006, Australia.
- The University of Sydney Nano Institute, Sydney, NSW 2006, Australia
| |
Collapse
|
3
|
Ong HC, Coimbra JTS, Ramos MJ, Xing B, Fernandes PA, García F. Beyond the TPP + "gold standard": a new generation mitochondrial delivery vector based on extended PN frameworks. Chem Sci 2023; 14:4126-4133. [PMID: 37063789 PMCID: PMC10094279 DOI: 10.1039/d2sc06508h] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/25/2022] [Accepted: 02/13/2023] [Indexed: 02/17/2023] Open
Abstract
Mitochondrial targeting represents an attractive strategy for treating metabolic, degenerative and hyperproliferative diseases, since this organelle plays key roles in essential cellular functions. Triphenylphosphonium (TPP+) moieties - the current "gold standard" - have been widely used as mitochondrial targeting vectors for a wide range of molecular cargo. Recently, further optimisation of the TPP+ platform drew considerable interest as a way to enhance mitochondrial therapies. However, although the modification of this system appears promising, the core structure of the TPP+ moiety remains largely unchanged. Thus, this study explored the use of aminophosphonium (PN+) and phosphazenylphosphonium (PPN+) main group frameworks as novel mitochondrial delivery vectors. The PPN+ moiety was found to be a highly promising platform for this purpose, owing to its unique electronic properties and high lipophilicity. This has been demonstrated by the high mitochondrial accumulation of a PPN+-conjugated fluorophore relative to its TPP+-conjugated counterpart, and has been further supported by density functional theory and molecular dynamics calculations, highlighting the PPN+ moiety's unusual electronic properties. These results demonstrate the potential of novel phosphorus-nitrogen based frameworks as highly effective mitochondrial delivery vectors over traditional TPP+ vectors.
Collapse
Affiliation(s)
- How Chee Ong
- School of Physical and Mathematical Sciences, Division of Chemistry and Biological Chemistry, Nanyang Technological University 21 Nanyang Link 637371 Singapore
| | - João T S Coimbra
- LAQV/REQUIMTE, Departamento de Química e Bioquímica, Faculdade de Ciências, Universidade do Porto Rua do Campo Alegre 687, s/n 4169-007 Porto Portugal
| | - Maria J Ramos
- LAQV/REQUIMTE, Departamento de Química e Bioquímica, Faculdade de Ciências, Universidade do Porto Rua do Campo Alegre 687, s/n 4169-007 Porto Portugal
| | - Bengang Xing
- School of Physical and Mathematical Sciences, Division of Chemistry and Biological Chemistry, Nanyang Technological University 21 Nanyang Link 637371 Singapore
| | - Pedro A Fernandes
- LAQV/REQUIMTE, Departamento de Química e Bioquímica, Faculdade de Ciências, Universidade do Porto Rua do Campo Alegre 687, s/n 4169-007 Porto Portugal
| | - Felipe García
- Departamento de Química Orgánica e Inorgánica, Facultad de Química, Universidad de Oviedo Avda Julian Claveria 8 33006 Asturias Spain
- School of Chemistry, Monash University Clayton Victoria 3800 Australia
| |
Collapse
|
4
|
Somoza M, Rial R, Liu Z, Llovo IF, Reis RL, Mosqueira J, Ruso JM. Microfluidic Fabrication of Gadolinium-Doped Hydroxyapatite for Theragnostic Applications. NANOMATERIALS (BASEL, SWITZERLAND) 2023; 13:501. [PMID: 36770462 PMCID: PMC9921701 DOI: 10.3390/nano13030501] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Figures] [Subscribe] [Scholar Register] [Received: 01/10/2023] [Revised: 01/18/2023] [Accepted: 01/23/2023] [Indexed: 06/18/2023]
Abstract
Among the several possible uses of nanoparticulated systems in biomedicine, their potential as theragnostic agents has received significant interest in recent times. In this work, we have taken advantage of the medical applications of Gadolinium as a contrast agent with the versatility and huge array of possibilities that microfluidics can help to create doped Hydroxyapatite nanoparticles with magnetic properties in an efficient and functional way. First, with the help of Computational Fluid Dynamics (CFD), we performed a complete and precise study of all the elements and phases of our device to guarantee that our microfluidic system worked in the laminar regime and was not affected by the presence of nanoparticles through the flow requisite that is essential to guarantee homogeneous diffusion between the elements or phases in play. Then the obtained biomaterials were physiochemically characterized by means of XRD, FE-SEM, EDX, confocal Raman microscopy, and FT-IR, confirming the successful incorporation of the lanthanide element Gadolinium in part of the Ca (II) binding sites. Finally, the magnetic characterization confirmed the paramagnetic behaviour of the nanoparticles, demonstrating that, with a simple and automatized system, it is possible to obtain advanced nanomaterials that can offer a promising and innovative solution in theragnostic applications.
Collapse
Affiliation(s)
- Manuel Somoza
- Soft Matter and Molecular Biophysics Group, Department of Applied Physics, University of Santiago de Compostela, 15782 Santiago de Compostela, Spain
| | - Ramón Rial
- Soft Matter and Molecular Biophysics Group, Department of Applied Physics, University of Santiago de Compostela, 15782 Santiago de Compostela, Spain
- 3B’s Research Group, I3Bs—Research Institute on Biomaterials, Biodegradables and Biomimetics, University of Minho, Headquarters of the European Institute of Excellence on Tissue Engineering and Regenerative Medicine AvePark—Parque de Ciência e Tecnologia Zona Industrial da Gandra Barco, 4805-017 Guimarães, Portugal
- ICVS/3B’s—PT Government Associate Laboratory, 4806-909 Braga, Portugal
| | - Zhen Liu
- Department of Physics and Engineering, Frostburg State University, Frostburg, MD 21532, USA
| | - Iago F. Llovo
- QMatterPhotonics, Departamento de Física de Partículas, Universidade de Santiago de Compostela, 15782 Santiago de Compostela, Spain
- Institute of Materials (iMATUS), Department of Applied Physics, Universidade de Santiago de Compostela, 15706 Santiago de Compostela, Spain
| | - Rui L. Reis
- 3B’s Research Group, I3Bs—Research Institute on Biomaterials, Biodegradables and Biomimetics, University of Minho, Headquarters of the European Institute of Excellence on Tissue Engineering and Regenerative Medicine AvePark—Parque de Ciência e Tecnologia Zona Industrial da Gandra Barco, 4805-017 Guimarães, Portugal
- ICVS/3B’s—PT Government Associate Laboratory, 4806-909 Braga, Portugal
| | - Jesús Mosqueira
- QMatterPhotonics, Departamento de Física de Partículas, Universidade de Santiago de Compostela, 15782 Santiago de Compostela, Spain
- Institute of Materials (iMATUS), Department of Applied Physics, Universidade de Santiago de Compostela, 15706 Santiago de Compostela, Spain
| | - Juan M. Ruso
- Soft Matter and Molecular Biophysics Group, Department of Applied Physics, University of Santiago de Compostela, 15782 Santiago de Compostela, Spain
| |
Collapse
|
5
|
Tabbakh F, Hosmane NS, Tajudin SM, Ghorashi AH, Morshedian N. Using 157Gd doped carbon and 157GdF4 nanoparticles in proton-targeted therapy for effectiveness enhancement and thermal neutron reduction: a simulation study. Sci Rep 2022; 12:17404. [PMID: 36258012 PMCID: PMC9579128 DOI: 10.1038/s41598-022-22429-0] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/10/2022] [Accepted: 10/14/2022] [Indexed: 01/10/2023] Open
Abstract
There are two major problems in proton therapy. (1) In comparison with the gamma-ray therapy, proton therapy has only ~ 10% greater biological effectiveness, and (2) the risk of the secondary neutrons in proton therapy is another unsolved problem. In this report, the increase of biological effectiveness in proton therapy has been evaluated with better performance than 11B in the presence of two proposed nanomaterials of 157GdF4 and 157Gd doped carbon with the thermal neutron reduction due to the presence of 157Gd isotope. The present study is based on the microanalysis calculations using GEANT4 Monte Carlo tool and GEANT4-DNA package for the strand breaks measurement. It was found that the proposed method will increase the effectiveness corresponding to the alpha particles by more than 100% and also, potentially will decrease the thermal neutrons fluence, significantly. Also, in this work, a discussion is presented on a significant contribution of the secondary alpha particles in total effectiveness in proton therapy.
Collapse
Affiliation(s)
- Farshid Tabbakh
- grid.459846.20000 0004 0611 7306Plasma and Nuclear Fusion Research School, Nuclear Science and Technology Research Institute, Tehran, 14155-1339 Iran
| | - Narayan S. Hosmane
- grid.261128.e0000 0000 9003 8934Department of Chemistry and Biochemistry, Northern Illinois University, DeKalb, IL 60115-2862 USA
| | - Suffian M. Tajudin
- grid.449643.80000 0000 9358 3479Faculty of Health Sciences, Universiti Sultan Zainal Abidin, Kuala Terengganu, Terengganu Malaysia
| | - Amir-Hossein Ghorashi
- grid.459846.20000 0004 0611 7306Plasma and Nuclear Fusion Research School, Nuclear Science and Technology Research Institute, Tehran, 14155-1339 Iran
| | - Nader Morshedian
- grid.459846.20000 0004 0611 7306Plasma and Nuclear Fusion Research School, Nuclear Science and Technology Research Institute, Tehran, 14155-1339 Iran
| |
Collapse
|
6
|
Nagarajan S, Poyer F, Fourmois L, Naud‐Martin D, Medjoubi K, Somogyi A, Schanne G, Henry L, Delsuc N, Policar C, Bertrand HC, Mahuteau‐Betzer F. Cellular Detection of a Mitochondria Targeted Brominated Vinyl Triphenylamine Optical Probe (TP−Br) by X‐Ray Fluorescence Microscopy. Chemistry 2022; 28:e202104424. [DOI: 10.1002/chem.202104424] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/13/2021] [Indexed: 11/06/2022]
Affiliation(s)
- Sounderya Nagarajan
- CNRS UMR9187, Inserm U1196, Chemistry and Modeling for the Biology of Cancer Institut Curie Université PSL 91400 Orsay France
- CNRS UMR9187, Inserm U1196, Chemistry and Modeling for the Biology of Cancer Université Paris-Saclay 91400 Orsay France
| | - Florent Poyer
- CNRS UMR9187, Inserm U1196, Chemistry and Modeling for the Biology of Cancer Institut Curie Université PSL 91400 Orsay France
- CNRS UMR9187, Inserm U1196, Chemistry and Modeling for the Biology of Cancer Université Paris-Saclay 91400 Orsay France
| | - Laura Fourmois
- CNRS UMR9187, Inserm U1196, Chemistry and Modeling for the Biology of Cancer Institut Curie Université PSL 91400 Orsay France
- CNRS UMR9187, Inserm U1196, Chemistry and Modeling for the Biology of Cancer Université Paris-Saclay 91400 Orsay France
| | - Delphine Naud‐Martin
- CNRS UMR9187, Inserm U1196, Chemistry and Modeling for the Biology of Cancer Institut Curie Université PSL 91400 Orsay France
- CNRS UMR9187, Inserm U1196, Chemistry and Modeling for the Biology of Cancer Université Paris-Saclay 91400 Orsay France
| | - Kadda Medjoubi
- Synchrotron SOLEIL, BP 48 Saint-Aubin 91192 Gif sur Yvette France
| | - Andrea Somogyi
- Synchrotron SOLEIL, BP 48 Saint-Aubin 91192 Gif sur Yvette France
| | - Gabrielle Schanne
- Laboratoire des biomolécules, LBM, Département de chimie Ecole normale supérieure PSL University Sorbonne université, CNRS 75005 Paris France
| | - Lucas Henry
- Laboratoire des biomolécules, LBM, Département de chimie Ecole normale supérieure PSL University Sorbonne université, CNRS 75005 Paris France
| | - Nicolas Delsuc
- Laboratoire des biomolécules, LBM, Département de chimie Ecole normale supérieure PSL University Sorbonne université, CNRS 75005 Paris France
| | - Clotilde Policar
- Laboratoire des biomolécules, LBM, Département de chimie Ecole normale supérieure PSL University Sorbonne université, CNRS 75005 Paris France
| | - Helene C. Bertrand
- Laboratoire des biomolécules, LBM, Département de chimie Ecole normale supérieure PSL University Sorbonne université, CNRS 75005 Paris France
| | - Florence Mahuteau‐Betzer
- CNRS UMR9187, Inserm U1196, Chemistry and Modeling for the Biology of Cancer Institut Curie Université PSL 91400 Orsay France
- CNRS UMR9187, Inserm U1196, Chemistry and Modeling for the Biology of Cancer Université Paris-Saclay 91400 Orsay France
| |
Collapse
|
7
|
Velarde F, Ezquerra S, Delbruyere X, Caicedo A, Hidalgo Y, Khoury M. Mesenchymal stem cell-mediated transfer of mitochondria: mechanisms and functional impact. Cell Mol Life Sci 2022; 79:177. [PMID: 35247083 PMCID: PMC11073024 DOI: 10.1007/s00018-022-04207-3] [Citation(s) in RCA: 22] [Impact Index Per Article: 11.0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/09/2021] [Revised: 01/27/2022] [Accepted: 02/11/2022] [Indexed: 12/13/2022]
Abstract
There is a steadily growing interest in the use of mitochondria as therapeutic agents. The use of mitochondria derived from mesenchymal stem/stromal cells (MSCs) for therapeutic purposes represents an innovative approach to treat many diseases (immune deregulation, inflammation-related disorders, wound healing, ischemic events, and aging) with an increasing amount of promising evidence, ranging from preclinical to clinical research. Furthermore, the eventual reversal, induced by the intercellular mitochondrial transfer, of the metabolic and pro-inflammatory profile, opens new avenues to the understanding of diseases' etiology, their relation to both systemic and local risk factors, and also leads to new therapeutic tools for the control of inflammatory and degenerative diseases. To this end, we illustrate in this review, the triggers and mechanisms behind the transfer of mitochondria employed by MSCs and the underlying benefits as well as the possible adverse effects of MSCs mitochondrial exchange. We relay the rationale and opportunities for the use of these organelles in the clinic as cell-based product.
Collapse
Affiliation(s)
- Francesca Velarde
- IMPACT, Center of Interventional Medicine for Precision and Advanced Cellular Therapy, Santiago, Chile
- Laboratory of Nano-Regenerative Medicine, Faculty of Medicine, Universidad de los Andes, Santiago, Chile
- Cells for Cells and REGENERO, The Chilean Consortium for Regenerative Medicine, Santiago, Chile
- Faculty of Medicine, Universidad de los Andes, Santiago, Chile
| | - Sarah Ezquerra
- IMPACT, Center of Interventional Medicine for Precision and Advanced Cellular Therapy, Santiago, Chile
- Laboratory of Nano-Regenerative Medicine, Faculty of Medicine, Universidad de los Andes, Santiago, Chile
- Cells for Cells and REGENERO, The Chilean Consortium for Regenerative Medicine, Santiago, Chile
| | - Xavier Delbruyere
- IMPACT, Center of Interventional Medicine for Precision and Advanced Cellular Therapy, Santiago, Chile
- Laboratory of Nano-Regenerative Medicine, Faculty of Medicine, Universidad de los Andes, Santiago, Chile
- Cells for Cells and REGENERO, The Chilean Consortium for Regenerative Medicine, Santiago, Chile
| | - Andres Caicedo
- Universidad San Francisco de Quito USFQ, Colegio de Ciencias de la Salud, Escuela de Medicina, Quito, Ecuador
- Universidad San Francisco de Quito USFQ, Instituto de Investigaciones en Biomedicina iBioMed, Quito, Ecuador
- Mito-Act Research Consortium, Quito, Ecuador
- Sistemas Médicos SIME, Universidad San Francisco de Quito USFQ, Quito, Ecuador
| | - Yessia Hidalgo
- IMPACT, Center of Interventional Medicine for Precision and Advanced Cellular Therapy, Santiago, Chile.
- Laboratory of Nano-Regenerative Medicine, Faculty of Medicine, Universidad de los Andes, Santiago, Chile.
- Cells for Cells and REGENERO, The Chilean Consortium for Regenerative Medicine, Santiago, Chile.
| | - Maroun Khoury
- IMPACT, Center of Interventional Medicine for Precision and Advanced Cellular Therapy, Santiago, Chile.
- Laboratory of Nano-Regenerative Medicine, Faculty of Medicine, Universidad de los Andes, Santiago, Chile.
- Cells for Cells and REGENERO, The Chilean Consortium for Regenerative Medicine, Santiago, Chile.
| |
Collapse
|
8
|
Windsor MSA, Busse M, Morrison DE, Baker RW, Hill LR, Rendina LM. Selective delivery of remarkably high levels of gadolinium to tumour cells using an arsonium salt. Chem Commun (Camb) 2021; 57:8806-8809. [PMID: 34382631 DOI: 10.1039/d1cc03082e] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/21/2022]
Abstract
The use of a triphenylarsonium vector for tumour cell-targeting leads to a dramatic increase in Gd3+ uptake in human glioblastoma multiforme cells by up to an order of magnitude over the isosteric triarylphosphonium analogue, with significant implications for 'theranostic' applications involving delivery of this important lanthanoid metal ion to tumour cells.
Collapse
|
9
|
Tong KKH, Hanif M, Movassaghi S, Sullivan MP, Lovett JH, Hummitzsch K, Söhnel T, Jamieson SMF, Bhargava SK, Harris HH, Hartinger CG. Triazolyl-Functionalized N-Heterocyclic Carbene Half-Sandwich Compounds: Coordination Mode, Reactivity and in vitro Anticancer Activity. ChemMedChem 2021; 16:3017-3026. [PMID: 34196118 DOI: 10.1002/cmdc.202100311] [Citation(s) in RCA: 4] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/05/2021] [Revised: 06/16/2021] [Indexed: 12/17/2022]
Abstract
We report investigations on the anticancer activity of organometallic [MII/III (η6 -p-cymene/η5 -pentamethylcyclopentadienyl)] (M=Ru, Os, Rh, and Ir) complexes of N-heterocyclic carbenes (NHCs) substituted with a triazolyl moiety. Depending on the precursors, the NHC ligands displayed either mono- or bidentate coordination via the NHC carbon atom or as N,C-donors. The metal complexes were investigated for their stability in aqueous solution, with the interpretation supported by density functional theory calculations, and reactivity to biomolecules. In vitro cytotoxicity studies suggested that the nature of both the metal center and the lipophilicity of the ligand determine the biological properties of this class of compounds. The IrIII complex 5 d bearing a benzimidazole-derived ligand was the most cytotoxic with an IC50 value of 10 μM against NCI-H460 non-small cell lung carcinoma cells. Cell uptake and distribution studies using X-ray fluorescence microscopy revealed localization of 5 d in the cytoplasm of cancer cells.
Collapse
Affiliation(s)
- Kelvin K H Tong
- School of Chemical Sciences, University of Auckland, Private Bag 92019, Auckland, 1142, New Zealand.,Maurice Wilkins Centre, University of Auckland, Private Bag 92019, Auckland, 1142, New Zealand
| | - Muhammad Hanif
- School of Chemical Sciences, University of Auckland, Private Bag 92019, Auckland, 1142, New Zealand.,Maurice Wilkins Centre, University of Auckland, Private Bag 92019, Auckland, 1142, New Zealand
| | - Sanam Movassaghi
- School of Chemical Sciences, University of Auckland, Private Bag 92019, Auckland, 1142, New Zealand
| | - Matthew P Sullivan
- School of Chemical Sciences, University of Auckland, Private Bag 92019, Auckland, 1142, New Zealand.,Maurice Wilkins Centre, University of Auckland, Private Bag 92019, Auckland, 1142, New Zealand.,School of Biological Sciences, University of Auckland, Private Bag 92019, Auckland, 1142, New Zealand
| | - James H Lovett
- Department of Chemistry, The University of Adelaide, Adelaide, SA 5005, Australia
| | - Katja Hummitzsch
- Discipline of Obstetrics and Gynecology, The University of Adelaide, Robinson Research Institute, Adelaide, SA 5005, Australia
| | - Tilo Söhnel
- School of Chemical Sciences, University of Auckland, Private Bag 92019, Auckland, 1142, New Zealand
| | - Stephen M F Jamieson
- Maurice Wilkins Centre, University of Auckland, Private Bag 92019, Auckland, 1142, New Zealand.,Auckland Cancer Society Research Centre, University of Auckland, Private Bag 92019, Auckland, 1142, New Zealand
| | - Suresh K Bhargava
- Centre for Advanced Materials and Industrial Chemistry, School of Science, RMIT University, Melbourne, Australia
| | - Hugh H Harris
- Department of Chemistry, The University of Adelaide, Adelaide, SA 5005, Australia
| | - Christian G Hartinger
- School of Chemical Sciences, University of Auckland, Private Bag 92019, Auckland, 1142, New Zealand.,Maurice Wilkins Centre, University of Auckland, Private Bag 92019, Auckland, 1142, New Zealand
| |
Collapse
|
10
|
Van Delinder KW, Khan R, Gräfe JL. Radiobiological impact of gadolinium neutron capture from proton therapy and alternative neutron sources using TOPAS-nBio. Med Phys 2021; 48:4004-4016. [PMID: 33959981 DOI: 10.1002/mp.14928] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/31/2020] [Revised: 04/06/2021] [Accepted: 04/26/2021] [Indexed: 02/02/2023] Open
Abstract
PURPOSE A multi-scale investigation of the biological properties of gadolinium neutron capture (GdNC) therapy with applications in particle therapy is conducted using the TOPAS Monte Carlo (MC) simulation code. The simulation results are used to quantify the amount of gadolinium dose enhancement produced as a result of the secondary neutron production from proton therapy scaled by measured data. MATERIALS AND METHODS MC modeling was performed using the radiobiology extension TOol for PArticle Simulation TOPAS-nBio MC simulation code to study the radiobiological effects produced from GdNC on a segment of DNA, a spherical cellular model, and from the modeling of previous experimental measurements. The average RBE values were calculated from two methods, microdosimetric kinematic (MK) and biological weighting r(y) within a 2 nm DNA segment for GdNC. The single-strand breaks (SSBs) and double-strand breaks (DSBs) were calculated from within the nucleus of a 20 µm diameter, spherical cell model. From a previous experimental proton therapy measurement using a spread-out Bragg peak (SOBP) of 4.5-9.5 cm and a delivered absorbed dose of 10.4 Gy, the amount of Gd neutron captures was calculated and used to quantify the amount of GdNC absolute dose from particle therapy. RESULTS The average RBE from microdosimetric kinematic and biological weighting was 1.35, and 1.70 for a 10% cell survival on HSG cell-line and weighting function data from early intestinal tolerance of mice. From a central isotropic GdNC source, the energy deposition is found to decrease from roughly 2.7 eV per capture down to approximately 0.01 eV per capture, a drop of two orders of magnitude within 50 nm. This result suggests that Gd needs to be close to the DNA (within 10-20 nm) in order for neutron capture to induce a significant dose enhancement due to the short-range electrons emitted after Gd neutron capture. Within a spherical cell model, the SSBs, and DSBs were determined to be 39 and 1.5 per neutron capture, respectively. From the total neutron captures produced from an experimental proton therapy measurement on a 3000 PPM Gd solution, an insignificant absolute Gd dose enhancement was quantified to be 5.4 × 10-6 Gy per Gy of administered proton dose. CONCLUSION From this study and literature review, the production of secondary thermal neutrons from proton therapy is determined to be a limiting factor and unlikely to produce a clinically useful dose enhancement for secondary neutron capture therapy. Moreover, alternative neutron sources, such as, a compact deuterium-tritium (D-T) neutron generator, a "high yield" deuterium-deuterium (D-D) generator, or an industrial strength (100 mg) 252 Cf source were investigated, with the 252 Cf source the most likely to be capable of producing enough neutrons for 1 Gy of localized GdNC absolute dose within a reasonable treatment time.
Collapse
Affiliation(s)
- Kurt W Van Delinder
- Department of Physics, Faculty of Science, Ryerson University, 350 Victoria St., Toronto, ON, M5B 2K3, Canada
| | - Rao Khan
- Department of Radiation Oncology, Medical Physics Division, Washington University School of Medicine, 660 S Euclid Ave, St Louis, MO, 63110, USA
| | - James L Gräfe
- Department of Physics, Faculty of Science, Ryerson University, 350 Victoria St., Toronto, ON, M5B 2K3, Canada
| |
Collapse
|
11
|
Yang Y, Zhou Z, Wei ZZ, Qin QP, Yang L, Liang H. High anticancer activity and apoptosis- and autophagy-inducing properties of novel lanthanide(III) complexes bearing 8-hydroxyquinoline- N-oxide and 1,10-phenanthroline. Dalton Trans 2021; 50:5828-5834. [PMID: 33949529 DOI: 10.1039/d1dt00450f] [Citation(s) in RCA: 24] [Impact Index Per Article: 8.0] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/14/2022]
Abstract
In the quest for rare earth metal complexes with enhanced cancer chemotherapeutic properties, the discovery of seven lanthanide(iii) complexes bearing 8-hydroxyquinoline-N-oxide (NQ) and 1,10-phenanthroline (phen) ligands, i.e., [SmIII(NQ)(phen)(H2O)Cl2] (Ln1), [EuII(NQ)(phen)(H2O)Cl2] (Ln2), [GdIII(NQ)(phen)(H2O)Cl2] (Ln3), [DyIII(NQ)(phen)(H2O)Cl2] (Ln4), [HoIII(NQ)(phen)(H2O)Cl2] (Ln5), [ErIII(NQ)(phen)(H2O)Cl2] (Ln6), and [YbIII(NQ)(phen)(H2O)Cl2] (Ln7), as potential anticancer drugs is described. Complexes Ln1-Ln7 exhibit high antiproliferative activity against cisplatin-resistant A549/DDP cells (IC50 = 0.025-0.097 μM) and low toxicity to normal HL-7702 cells. Moreover, complex Ln1, and to a lesser extent Ln7, can upregulate the expression of LC3 and Beclin1 and downregulate p62 to induce apoptosis in cisplatin-resistant A549/DDP cell lines, which is related to the cell autophagy-inducing properties of Ln1 and Ln7. Furthermore, in vivo assays suggest that Ln1 significantly inhibits A549/DDP xenograft tumor growth (56.5%). These results indicate that lanthanide(iii) complex Ln1 is a promising candidate as an anticancer drug against cisplatin-resistant A549/DDP cells.
Collapse
Affiliation(s)
- Yan Yang
- Guangxi Key Lab of Agricultural Resources Chemistry and Biotechnology, College of Chemistry and Food Science, Yulin Normal University, 1303 Jiaoyudong Road, Yulin 537000, PR China.
| | - Zhen Zhou
- Guangxi Key Lab of Agricultural Resources Chemistry and Biotechnology, College of Chemistry and Food Science, Yulin Normal University, 1303 Jiaoyudong Road, Yulin 537000, PR China.
| | - Zu-Zhuang Wei
- School of Pharmaceutical Sciences, Sun Yat-sen University, Guangzhou 510006, P. R. China
| | - Qi-Pin Qin
- Guangxi Key Lab of Agricultural Resources Chemistry and Biotechnology, College of Chemistry and Food Science, Yulin Normal University, 1303 Jiaoyudong Road, Yulin 537000, PR China. and State Key Laboratory for the Chemistry and Molecular Engineering of Medicinal Resources, School of Chemistry and Pharmacy, Guangxi Normal University, 15 Yucai Road, Guilin 541004, PR China.
| | - Lin Yang
- Guangxi Key Lab of Agricultural Resources Chemistry and Biotechnology, College of Chemistry and Food Science, Yulin Normal University, 1303 Jiaoyudong Road, Yulin 537000, PR China.
| | - Hong Liang
- State Key Laboratory for the Chemistry and Molecular Engineering of Medicinal Resources, School of Chemistry and Pharmacy, Guangxi Normal University, 15 Yucai Road, Guilin 541004, PR China.
| |
Collapse
|
12
|
Osuchowski M, Osuchowski F, Latos W, Kawczyk-Krupka A. The Use of Upconversion Nanoparticles in Prostate Cancer Photodynamic Therapy. Life (Basel) 2021; 11:life11040360. [PMID: 33921611 PMCID: PMC8073589 DOI: 10.3390/life11040360] [Citation(s) in RCA: 8] [Impact Index Per Article: 2.7] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/28/2021] [Revised: 04/07/2021] [Accepted: 04/15/2021] [Indexed: 12/30/2022] Open
Abstract
Photodynamic Therapy (PDT) is a cancer treatment that uses light, a photosensitizer, and oxygen to destroy tumors. This article is a review of approaches to the treatment of prostate cancer applying upconversion nanoparticles (UCNPs). UCNPs have become a phenomenon that are rapidly gaining recognition in medicine. They have proven to be highly selective and specific and present a powerful tool in the diagnosis and treatment of prostate cancer. Prostate cancer is a huge health problem in Western countries. Its early detection can significantly improve patients’ prognosis, but currently used diagnostic methods leave much to be desired. Recently developed methodologies regarding UCNP research between the years 2021 and 2014 for prostate cancer PDT will also be discussed. Current limitations in PDT include tissue irradiation with visible wavelengths that have a short tissue penetration depth. PDT with the objectives to synthesize UCNPs composed of a lanthanide core with a coating of adsorbed dye that will generate fluorescence after excitation with near-infrared light to illuminate deep tissue is a subject of intense research in prostate cancer.
Collapse
Affiliation(s)
- Michał Osuchowski
- College of Medical Sciences, University of Rzeszów, 35-310 Rzeszów, Poland; (M.O.); (F.O.)
| | - Filip Osuchowski
- College of Medical Sciences, University of Rzeszów, 35-310 Rzeszów, Poland; (M.O.); (F.O.)
| | | | - Aleksandra Kawczyk-Krupka
- Department of Internal Medicine, Angiology and Physical Medicine, Center for Laser Diagnostics and Therapy, Medical University of Silesia in Katowice, 41-902 Bytom, Poland
- Correspondence:
| |
Collapse
|
13
|
Hall AJ, Robertson AG, Hill LR, Rendina LM. Synthesis and tumour cell uptake studies of gadolinium(III)-phosphonium complexes. Sci Rep 2021; 11:598. [PMID: 33436690 PMCID: PMC7804430 DOI: 10.1038/s41598-020-79893-9] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/13/2020] [Accepted: 12/14/2020] [Indexed: 11/09/2022] Open
Abstract
The synthesis of a new series of Gd(III)-arylphosphonium complexes is described and the solution stability of selected compounds is reported. Their lipophilicity and uptake in human glial (SVG p12) and human glioblastoma multiforme (T98G) cell lines are presented. The in vitro cytotoxicity of all complexes was determined to be low at therapeutically-relevant concentrations. Selected Gd(III) complexes are potential candidates for further investigation as theranostic agents.
Collapse
Affiliation(s)
- Andrew J Hall
- School of Chemistry, The University of Sydney, Sydney, NSW, 2006, Australia
| | - Amy G Robertson
- School of Chemistry, The University of Sydney, Sydney, NSW, 2006, Australia
| | - Leila R Hill
- School of Chemistry, The University of Sydney, Sydney, NSW, 2006, Australia
| | - Louis M Rendina
- School of Chemistry, The University of Sydney, Sydney, NSW, 2006, Australia.
- The University of Sydney Nano Institute, Sydney, NSW, 2006, Australia.
| |
Collapse
|
14
|
Schanne G, Henry L, Ong HC, Somogyi A, Medjoubi K, Delsuc N, Policar C, García F, Bertrand HC. Rhenium carbonyl complexes bearing methylated triphenylphosphonium cations as antibody-free mitochondria trackers for X-ray fluorescence imaging. Inorg Chem Front 2021. [DOI: 10.1039/d1qi00542a] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/13/2023]
Abstract
A convenient rhenium-based multimodal mitochondrial-targeted probe compatible with Synchrotron Radiation X-ray Fluorescence nano-imaging.
Collapse
Affiliation(s)
- Gabrielle Schanne
- Laboratoire des biomolécules
- LBM
- Département de chimie
- Ecole normale supérieure
- PSL University
| | - Lucas Henry
- Laboratoire des biomolécules
- LBM
- Département de chimie
- Ecole normale supérieure
- PSL University
| | - How Chee Ong
- School of Physical and Mathematical Sciences
- Division of Chemistry and Biological Chemistry
- Nanyang Technological University
- Singapore
| | - Andrea Somogyi
- Synchrotron SOLEIL
- BP 48
- Saint-Aubin
- 91192 Gif sur Yvette
- France
| | - Kadda Medjoubi
- Synchrotron SOLEIL
- BP 48
- Saint-Aubin
- 91192 Gif sur Yvette
- France
| | - Nicolas Delsuc
- Laboratoire des biomolécules
- LBM
- Département de chimie
- Ecole normale supérieure
- PSL University
| | - Clotilde Policar
- Laboratoire des biomolécules
- LBM
- Département de chimie
- Ecole normale supérieure
- PSL University
| | - Felipe García
- School of Physical and Mathematical Sciences
- Division of Chemistry and Biological Chemistry
- Nanyang Technological University
- Singapore
| | - Helene C. Bertrand
- Laboratoire des biomolécules
- LBM
- Département de chimie
- Ecole normale supérieure
- PSL University
| |
Collapse
|
15
|
Tong KKH, Hanif M, Lovett JH, Hummitzsch K, Harris HH, Söhnel T, Jamieson SMF, Hartinger CG. Thiourea-Derived Chelating Ligands and Their Organometallic Compounds: Investigations into Their Anticancer Activity. Molecules 2020; 25:molecules25163661. [PMID: 32796732 PMCID: PMC7464268 DOI: 10.3390/molecules25163661] [Citation(s) in RCA: 7] [Impact Index Per Article: 1.8] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/03/2020] [Revised: 08/06/2020] [Accepted: 08/07/2020] [Indexed: 11/16/2022] Open
Abstract
Thiones have been investigated as ligands in metal complexes with catalytic and biological activity. We report the synthesis, characterization, and biological evaluation of a series of MII/III complexes of the general formulae [MII(cym)(L)Cl]X (cym = η6-p-cymene) or [MIII(Cp*)(L)Cl]X (Cp* = η5-pentamethylcyclopentadienyl), where X = Cl- or PF6-, and L represents heterocyclic derivatives of thiourea. The thiones feature a benzyl-triazolyl pendant and they act as bidentate ligands via N,S-coordination to the metal centers. Several derivatives have been investigated by single-crystal X-ray diffraction analysis. NMR investigations showed a counterion-dependent shift of several protons due to the interaction with the counterions. These NMR investigations were complemented with X-ray diffraction analysis data and the effects of different counterions on the secondary coordination sphere were also investigated by DFT calculations. In biological studies, the Ir benzimidazole derivative was found to accumulate in the cytoplasm and it was the most cytotoxic derivative investigated.
Collapse
Affiliation(s)
- Kelvin K. H. Tong
- School of Chemical Sciences, University of Auckland, Private Bag 92019, Auckland 1142, New Zealand; (K.K.H.T.); (M.H.); (T.S.)
| | - Muhammad Hanif
- School of Chemical Sciences, University of Auckland, Private Bag 92019, Auckland 1142, New Zealand; (K.K.H.T.); (M.H.); (T.S.)
| | - James H. Lovett
- Department of Chemistry, The University of Adelaide, Adelaide, SA 5005, Australia; (J.H.L.); (H.H.H.)
| | - Katja Hummitzsch
- Discipline of Obstetrics and Gynecology, The University of Adelaide, Robinson Research Institute, Adelaide, SA 5005, Australia;
| | - Hugh H. Harris
- Department of Chemistry, The University of Adelaide, Adelaide, SA 5005, Australia; (J.H.L.); (H.H.H.)
| | - Tilo Söhnel
- School of Chemical Sciences, University of Auckland, Private Bag 92019, Auckland 1142, New Zealand; (K.K.H.T.); (M.H.); (T.S.)
| | - Stephen M. F. Jamieson
- Auckland Cancer Society Research Centre, University of Auckland, Private Bag 92019, Auckland 1142, New Zealand;
| | - Christian G. Hartinger
- School of Chemical Sciences, University of Auckland, Private Bag 92019, Auckland 1142, New Zealand; (K.K.H.T.); (M.H.); (T.S.)
- Correspondence: ; Tel.: +64-9-373-7599-83220
| |
Collapse
|
16
|
Van Delinder KW, Khan R, Gräfe JL. Neutron activation of gadolinium for ion therapy: a Monte Carlo study of charged particle beams. Sci Rep 2020; 10:13417. [PMID: 32770174 PMCID: PMC7414875 DOI: 10.1038/s41598-020-70429-9] [Citation(s) in RCA: 6] [Impact Index Per Article: 1.5] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/16/2020] [Accepted: 07/28/2020] [Indexed: 12/23/2022] Open
Abstract
This study investigates the photon production from thermal neutron capture in a gadolinium (Gd) infused tumor as a result of secondary neutrons from particle therapy. Gadolinium contrast agents used in MRI are distributed within the tumor volume and can act as neutron capture agents. As a result of particle therapy, secondary neutrons are produced and absorbed by Gd in the tumor providing potential enhanced localized dose in addition to a signature photon spectrum that can be used to produce an image of the Gd enriched tumor. To investigate this imaging application, Monte Carlo (MC) simulations were performed for 10 different particles using a 5-10 cm spread out-Bragg peak (SOBP) centered on an 8 cm3, 3 mg/g Gd infused tumor. For a proton beam, 1.9 × 106 neutron captures per RBE weighted Gray Equivalent dose (GyE) occurred within the Gd tumor region. Antiprotons ([Formula: see text]), negative pions (- π), and helium (He) ion beams resulted in 10, 17 and 1.3 times larger Gd neutron captures per GyE than protons, respectively. Therefore, the characteristic photon based spectroscopic imaging and secondary Gd dose enhancement could be viable and likely beneficial for these three particles.
Collapse
Affiliation(s)
- Kurt W Van Delinder
- Department of Physics, Faculty of Science, Ryerson University, 350 Victoria St., Toronto, ON, M5B 2K3, Canada.
| | - Rao Khan
- Medical Physics Division, Department of Radiation Oncology, Washington University School of Medicine, 660 S Euclid Ave, St Louis, MO, 63110, USA
| | - James L Gräfe
- Department of Physics, Faculty of Science, Ryerson University, 350 Victoria St., Toronto, ON, M5B 2K3, Canada
| |
Collapse
|
17
|
Truong D, Sullivan MP, Tong KKH, Steel TR, Prause A, Lovett JH, Andersen JW, Jamieson SMF, Harris HH, Ott I, Weekley CM, Hummitzsch K, Söhnel T, Hanif M, Metzler-Nolte N, Goldstone DC, Hartinger CG. Potent Inhibition of Thioredoxin Reductase by the Rh Derivatives of Anticancer M(arene/Cp*)(NHC)Cl 2 Complexes. Inorg Chem 2020; 59:3281-3289. [PMID: 32073260 DOI: 10.1021/acs.inorgchem.9b03640] [Citation(s) in RCA: 43] [Impact Index Per Article: 10.8] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/01/2023]
Abstract
Metal complexes provide a versatile platform to develop novel anticancer pharmacophores, and they form stable compounds with N-heterocyclic carbene (NHC) ligands, some of which have been shown to inhibit the cancer-related selenoenzyme thioredoxin reductase (TrxR). To expand a library of isostructural NHC complexes, we report here the preparation of RhIII- and IrIII(Cp*)(NHC)Cl2 (Cp* = η5-pentamethylcyclopentadienyl) compounds and comparison of their properties to the RuII- and OsII(cym) analogues (cym = η6-p-cymene). Like the RuII- and OsII(cym) complexes, the RhIII- and IrIII(Cp*) derivatives exhibit cytotoxic activity with half maximal inhibitory concentration (IC50) values in the low micromolar range against a set of four human cancer cell lines. In studies on the uptake and localization of the compounds in cancer cells by X-ray fluorescence microscopy, the Ru and Os derivatives were shown to accumulate in the cytoplasmic region of treated cells. In an attempt to tie the localization of the compounds to the inhibition of the tentative target TrxR, it was surprisingly found that only the Rh complexes showed significant inhibitory activity at IC50 values of ∼1 μM, independent of the substituents on the NHC ligand. This indicates that, although TrxR may be a potential target for anticancer metal complexes, it is unlikely the main target or the sole target for the Ru, Os, and Ir compounds described here, and other targets should be considered. In contrast, Rh(Cp*)(NHC)Cl2 complexes may be a scaffold for the development of TrxR inhibitors.
Collapse
Affiliation(s)
| | | | | | | | - Andre Prause
- Institute of Medicinal and Pharmaceutical Chemistry, Technische Universität Braunschweig, Beethovenstr. 55, Braunschweig D-38106, Germany
| | | | | | - Stephen M F Jamieson
- Auckland Cancer Society Research Centre, University of Auckland, Auckland 1023, New Zealand
| | | | - Ingo Ott
- Institute of Medicinal and Pharmaceutical Chemistry, Technische Universität Braunschweig, Beethovenstr. 55, Braunschweig D-38106, Germany
| | - Claire M Weekley
- Bio21 Institute and Department of Biochemistry and Molecular Biology, The University of Melbourne, Melbourne 3052, VIC, Australia
| | | | | | | | - Nils Metzler-Nolte
- Inorganic Chemistry I-Bioinorganic Chemistry, Faculty of Chemistry and Biochemistry, Ruhr University Bochum, Universitaetsstrasse, Bochum 44801, Germany
| | | | | |
Collapse
|
18
|
Van Delinder KW, Crawford D, Zhang T, Khan R, Gräfe JL. Investigating neutron activated contrast agent imaging for tumor localization in proton therapy: a feasibility study for proton neutron gamma-x detection (PNGXD). Phys Med Biol 2020; 65:035005. [PMID: 31851952 DOI: 10.1088/1361-6560/ab63b5] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/11/2022]
Abstract
Proton neutron gamma-x detection (PNGXD) is a novel imaging concept being investigated for tumor localization during proton therapy that uses secondary neutron interactions with a gadolinium contrast agent (GDCA) to produce characteristic photons within the 40-200 keV energy region. The purpose of this study is to experimentally investigate the feasibility of implementing this procedure by performing experimental measurements on a passive double scattering proton treatment unit. Five experimental measurements were performed with varying concentrations and irradiation conditions. Photon spectra were measured with a 25 mm2, 1 mm thick uncollimated X-123 CdTe spectrometer. For a 10.4 Gy administration on a 100 ml volume phantom with 10 mg g-1 Gd solution placed in a water phantom, 1129 ± 184 K-shell Gd counts were detected. For an administered dose of 21 Gy and the same Gd solution measured in air, resulted in 3296 ± 256 counts. A total of 1094 ± 171, 421 ± 150 and 23 ± 141 K-shell Gd counts were measured for Gd concentrations of 10 mg g-1, 1 mg g-1 and 0 mg g-1 for 7 Gy dose in air. The signal to noise ratio for these five measurements were: 7, 15, 6, 3, and 0.2, respectively. The spectrum contained 43 keV K α and 49 keV K β peaks, however a small amount of 79.5 and 181.9 keV prompt gamma rays were detected from gadolinium neutron capture. This discrepancy is due to a drop in the intrinsic detection efficiency of the CdTe spectrometer over this energy range. The measurements were compared with Monte-Carlo simulation to determine the contributions of Gd neutron capture from internal and external neutrons on a passive scattering proton therapy unit and to investigate the discrepancy in detected characteristic x-rays versus prompt gamma rays.
Collapse
Affiliation(s)
- Kurt W Van Delinder
- Department of Physics, Faculty of Science, Ryerson University, 350 Victoria St., Toronto, Ontario M5B 2K3, Canada. Author to whom any correspondence should be addressed
| | | | | | | | | |
Collapse
|
19
|
Konkankit CC, Lovett J, Harris HH, Wilson JJ. X-Ray fluorescence microscopy reveals that rhenium(i) tricarbonyl isonitrile complexes remain intact in vitro. Chem Commun (Camb) 2020; 56:6515-6518. [DOI: 10.1039/d0cc02451a] [Citation(s) in RCA: 18] [Impact Index Per Article: 4.5] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/17/2022]
Abstract
An endoplasmic reticulum stress-inducing rhenium isonitrile complex was investigated for its axial ligand stability in living cells using X-ray fluorescence microscopy.
Collapse
Affiliation(s)
| | - James Lovett
- Department of Chemistry
- The University of Adelaide
- Australia
| | - Hugh H. Harris
- Department of Chemistry
- The University of Adelaide
- Australia
| | - Justin J. Wilson
- Department of Chemistry and Chemical Biology
- Cornell University
- Ithaca
- USA
| |
Collapse
|
20
|
Wysokińska E, Cichos J, Kowalczyk A, Karbowiak M, Strządała L, Bednarkiewicz A, Kałas W. Toxicity Mechanism of Low Doses of NaGdF₄:Yb 3+,Er 3+ Upconverting Nanoparticles in Activated Macrophage Cell Lines. Biomolecules 2019; 9:biom9010014. [PMID: 30609856 PMCID: PMC6359000 DOI: 10.3390/biom9010014] [Citation(s) in RCA: 24] [Impact Index Per Article: 4.8] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/20/2018] [Revised: 12/15/2018] [Accepted: 12/21/2018] [Indexed: 02/03/2023] Open
Abstract
Gadolinium-doped nanoparticles (NPs) are regarded as promising luminescent probes. In this report, we studied details of toxicity mechanism of low doses of NaGdF4-based fluorescent nanoparticles in activated RAW264.7, J774A.1 macrophages. These cell lines were specifically sensitive to the treatment with nanoparticles. Using nanoparticles of three different sizes, but with a uniform zeta potential (about −11 mV), we observed rapid uptake of NPs by the cells, resulting in the increased lysosomal compartment and subsequent superoxide induction along with a decrease in mitochondrial potential, indicating the impairment of mitochondrial homeostasis. At the molecular level, this led to upregulation of proapoptotic Bax and downregulation of anti-apoptotic Bcl-2, which triggered the apoptosis with phosphatidylserine externalization, caspase-3 activation and DNA fragmentation. We provide a time frame of the toxicity process by presenting data from different time points. These effects were present regardless of the size of nanoparticles. Moreover, despite the stability of NaGdF4 nanoparticles at low pH, we identified cell acidification as an essential prerequisite of cytotoxic reaction using acidification inhibitors (NH4Cl or Bafilomycin A1). Therefore, approaching the evaluation of the biocompatibility of such materials, one should keep in mind that toxicity could be revealed only in specific cells. On the other hand, designing gadolinium-doped NPs with increased resistance to harsh conditions of activated macrophage phagolysosomes should prevent NP decomposition, concurrent gadolinium release, and thus the elimination of its toxicity.
Collapse
Affiliation(s)
- Edyta Wysokińska
- Hirszfeld Institute of Immunology and Experimental Therapy, PAS, 53-114 Wroclaw, Poland.
| | - Jakub Cichos
- Faculty of Chemistry, University of Wroclaw, 50-383 Wroclaw, Poland.
| | | | | | - Leon Strządała
- Hirszfeld Institute of Immunology and Experimental Therapy, PAS, 53-114 Wroclaw, Poland.
| | | | - Wojciech Kałas
- Hirszfeld Institute of Immunology and Experimental Therapy, PAS, 53-114 Wroclaw, Poland.
| |
Collapse
|
21
|
Safavi-Naeini M, Chacon A, Guatelli S, Franklin DR, Bambery K, Gregoire MC, Rosenfeld A. Opportunistic dose amplification for proton and carbon ion therapy via capture of internally generated thermal neutrons. Sci Rep 2018; 8:16257. [PMID: 30390002 PMCID: PMC6215016 DOI: 10.1038/s41598-018-34643-w] [Citation(s) in RCA: 22] [Impact Index Per Article: 3.7] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/11/2018] [Accepted: 10/22/2018] [Indexed: 12/11/2022] Open
Abstract
This paper presents Neutron Capture Enhanced Particle Therapy (NCEPT), a method for enhancing the radiation dose delivered to a tumour relative to surrounding healthy tissues during proton and carbon ion therapy by capturing thermal neutrons produced inside the treatment volume during irradiation. NCEPT utilises extant and in-development boron-10 and gadolinium-157-based drugs from the related field of neutron capture therapy. Using Monte Carlo simulations, we demonstrate that a typical proton or carbon ion therapy treatment plan generates an approximately uniform thermal neutron field within the target volume, centred around the beam path. The tissue concentrations of neutron capture agents required to obtain an arbitrary 10% increase in biological effective dose are estimated for realistic treatment plans, and compared to concentrations previously reported in the literature. We conclude that the proposed method is theoretically feasible, and can provide a worthwhile improvement in the dose delivered to the tumour relative to healthy tissue with readily achievable concentrations of neutron capture enhancement drugs.
Collapse
Affiliation(s)
- Mitra Safavi-Naeini
- Australian Nuclear Science and Technology Organisation (ANSTO), Sydney, Australia.
- Centre for Medical Radiation Physics, University of Wollongong, Sydney, Australia.
| | - Andrew Chacon
- Australian Nuclear Science and Technology Organisation (ANSTO), Sydney, Australia
- Centre for Medical Radiation Physics, University of Wollongong, Sydney, Australia
| | - Susanna Guatelli
- Centre for Medical Radiation Physics, University of Wollongong, Sydney, Australia
| | - Daniel R Franklin
- Faculty of Engineering & IT, University of Technology Sydney, Sydney, Australia
| | - Keith Bambery
- Australian Nuclear Science and Technology Organisation (ANSTO), Sydney, Australia
| | - Marie-Claude Gregoire
- Australian Nuclear Science and Technology Organisation (ANSTO), Sydney, Australia
- Centre for Medical Radiation Physics, University of Wollongong, Sydney, Australia
| | - Anatoly Rosenfeld
- Centre for Medical Radiation Physics, University of Wollongong, Sydney, Australia
| |
Collapse
|
22
|
Tumor cell uptake and selectivity of gadolinium(III)-phosphonium complexes: The role of delocalisation at the phosphonium centre. J Inorg Biochem 2017; 177:313-321. [DOI: 10.1016/j.jinorgbio.2017.07.004] [Citation(s) in RCA: 8] [Impact Index Per Article: 1.1] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/13/2017] [Revised: 06/21/2017] [Accepted: 07/02/2017] [Indexed: 12/22/2022]
|
23
|
Zielonka J, Sikora A, Hardy M, Ouari O, Vasquez-Vivar J, Cheng G, Lopez M, Kalyanaraman B. Mitochondria-Targeted Triphenylphosphonium-Based Compounds: Syntheses, Mechanisms of Action, and Therapeutic and Diagnostic Applications. Chem Rev 2017; 117:10043-10120. [PMID: 28654243 PMCID: PMC5611849 DOI: 10.1021/acs.chemrev.7b00042] [Citation(s) in RCA: 921] [Impact Index Per Article: 131.6] [Reference Citation Analysis] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/06/2023]
Abstract
Mitochondria are recognized as one of the most important targets for new drug design in cancer, cardiovascular, and neurological diseases. Currently, the most effective way to deliver drugs specifically to mitochondria is by covalent linking a lipophilic cation such as an alkyltriphenylphosphonium moiety to a pharmacophore of interest. Other delocalized lipophilic cations, such as rhodamine, natural and synthetic mitochondria-targeting peptides, and nanoparticle vehicles, have also been used for mitochondrial delivery of small molecules. Depending on the approach used, and the cell and mitochondrial membrane potentials, more than 1000-fold higher mitochondrial concentration can be achieved. Mitochondrial targeting has been developed to study mitochondrial physiology and dysfunction and the interaction between mitochondria and other subcellular organelles and for treatment of a variety of diseases such as neurodegeneration and cancer. In this Review, we discuss efforts to target small-molecule compounds to mitochondria for probing mitochondria function, as diagnostic tools and potential therapeutics. We describe the physicochemical basis for mitochondrial accumulation of lipophilic cations, synthetic chemistry strategies to target compounds to mitochondria, mitochondrial probes, and sensors, and examples of mitochondrial targeting of bioactive compounds. Finally, we review published attempts to apply mitochondria-targeted agents for the treatment of cancer and neurodegenerative diseases.
Collapse
Affiliation(s)
- Jacek Zielonka
- Department of Biophysics, Medical College of Wisconsin, 8701 Watertown Plank Road, Milwaukee, WI 53226, United States
- Free Radical Research Center, Medical College of Wisconsin, 8701 Watertown Plank Road, Milwaukee, WI 53226, United States
- Cancer Center, Medical College of Wisconsin, 8701 Watertown Plank Road, Milwaukee, WI 53226, United States
| | - Adam Sikora
- Institute of Applied Radiation Chemistry, Lodz University of Technology, ul. Wroblewskiego 15, 93-590 Lodz, Poland
| | - Micael Hardy
- Aix Marseille Univ, CNRS, ICR, UMR 7273, 13013 Marseille, France
| | - Olivier Ouari
- Aix Marseille Univ, CNRS, ICR, UMR 7273, 13013 Marseille, France
| | - Jeannette Vasquez-Vivar
- Department of Biophysics, Medical College of Wisconsin, 8701 Watertown Plank Road, Milwaukee, WI 53226, United States
- Free Radical Research Center, Medical College of Wisconsin, 8701 Watertown Plank Road, Milwaukee, WI 53226, United States
| | - Gang Cheng
- Department of Biophysics, Medical College of Wisconsin, 8701 Watertown Plank Road, Milwaukee, WI 53226, United States
- Free Radical Research Center, Medical College of Wisconsin, 8701 Watertown Plank Road, Milwaukee, WI 53226, United States
| | - Marcos Lopez
- Translational Biomedical Research Group, Biotechnology Laboratories, Cardiovascular Foundation of Colombia, Carrera 5a No. 6-33, Floridablanca, Santander, Colombia, 681003
- Graduate Program of Biomedical Sciences, Faculty of Health, Universidad del Valle, Calle 4B No. 36-00, Cali, Colombia, 760032
| | - Balaraman Kalyanaraman
- Department of Biophysics, Medical College of Wisconsin, 8701 Watertown Plank Road, Milwaukee, WI 53226, United States
- Free Radical Research Center, Medical College of Wisconsin, 8701 Watertown Plank Road, Milwaukee, WI 53226, United States
- Cancer Center, Medical College of Wisconsin, 8701 Watertown Plank Road, Milwaukee, WI 53226, United States
| |
Collapse
|
24
|
Sanchez‐Cano C, Romero‐Canelón I, Yang Y, Hands‐Portman IJ, Bohic S, Cloetens P, Sadler PJ. Synchrotron X-Ray Fluorescence Nanoprobe Reveals Target Sites for Organo-Osmium Complex in Human Ovarian Cancer Cells. Chemistry 2017; 23:2512-2516. [PMID: 28012260 PMCID: PMC5412901 DOI: 10.1002/chem.201605911] [Citation(s) in RCA: 62] [Impact Index Per Article: 8.9] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/19/2016] [Revised: 12/23/2016] [Indexed: 01/17/2023]
Abstract
A variety of transition metal complexes exhibit anticancer activity, but their target sites in cells need to be identified and mechanisms of action elucidated. Here, it was found that the sub-cellular distribution of [Os(η6 -p-cym)(Azpy-NMe2 )I]+ (p-cym=p-cymene, Azpy-NMe2 =2-(p-[dimethylamino]phenylazo)pyridine) (1), a promising drug candidate, can be mapped in human ovarian cancer cells at pharmacological concentrations using a synchrotron X-ray fluorescence nanoprobe (SXRFN). SXRFN data for Os, Zn, Ca, and P, as well as TEM and ICP analysis of mitochondrial fractions suggest localization of Os in mitochondria and not in the nucleus, accompanied by mobilization of Ca from the endoplasmic reticulum, a signaling event for cell death. These data are consistent with the ability of 1 to induce rapid bursts of reactive oxygen species and especially superoxide formed in the first step of O2 reduction in mitochondria. Such metabolic targeting differs from the action of Pt drugs, offering promise for combatting Pt resistance, which is a current clinical problem.
Collapse
Affiliation(s)
| | | | - Yang Yang
- ID16A beamline, ESRFThe European Synchrotron71 Avenue des Martyrs3800GrenobleFrance
| | | | - Sylvain Bohic
- ID16A beamline, ESRFThe European Synchrotron71 Avenue des Martyrs3800GrenobleFrance
- Inserm, U836, equipe 6, “Rayonnement synchrotron et recherches medicales”, GrenobleInstitut des Neurosciences38054GrenobleFrance
| | - Peter Cloetens
- ID16A beamline, ESRFThe European Synchrotron71 Avenue des Martyrs3800GrenobleFrance
| | - Peter J. Sadler
- Department of ChemistryUniversity of WarwickCoventryCV4 7ALUK
| |
Collapse
|
25
|
Kardashinsky M, Lengkeek N, Rendina LM. Synthesis and stability studies of Ga-67 labeled phosphonium salts. J Labelled Comp Radiopharm 2016; 60:4-11. [DOI: 10.1002/jlcr.3448] [Citation(s) in RCA: 5] [Impact Index Per Article: 0.6] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/17/2016] [Accepted: 08/30/2016] [Indexed: 11/05/2022]
Affiliation(s)
| | - Nigel Lengkeek
- ANSTO Life Sciences, Australian Nuclear Science and Technology Organisation; NSW 2232 Australia
| | - Louis M. Rendina
- School of Chemistry; The University of Sydney; Sydney NSW 2006 Australia
| |
Collapse
|
26
|
Lux F, Sancey L, Bianchi A, Crémillieux Y, Roux S, Tillement O. Gadolinium-based nanoparticles for theranostic MRI-radiosensitization. Nanomedicine (Lond) 2015; 10:1801-15. [PMID: 25715316 DOI: 10.2217/nnm.15.30] [Citation(s) in RCA: 68] [Impact Index Per Article: 7.6] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/19/2022] Open
Abstract
A rapid development of gadolinium-based nanoparticles is observed due to their attractive properties as MRI-positive contrast agents. Indeed, they display high relaxivity, adapted biodistribution and passive uptake in the tumor thanks to enhanced permeability and retention effect. In addition to these imaging properties, it has been recently shown that they can act as effective radiosensitizers under different types of irradiation (radiotherapy, neutron therapy or hadron therapy). These new therapeutic modalities pave the way to therapy guided by imaging and to personalized medicine.
Collapse
Affiliation(s)
- François Lux
- Institut Lumière Matière, UMR5306 Université Lyon 1-CNRS, Université de Lyon, 69622 Villeurbanne cedex, France
| | - Lucie Sancey
- Institut Lumière Matière, UMR5306 Université Lyon 1-CNRS, Université de Lyon, 69622 Villeurbanne cedex, France
| | - Andrea Bianchi
- Centre de Résonance Magnétique des Systèmes Biologiques, CNRS UMR5536, Université Bordeaux, Bordeaux, France
| | - Yannick Crémillieux
- Centre de Résonance Magnétique des Systèmes Biologiques, CNRS UMR5536, Université Bordeaux, Bordeaux, France
| | - Stéphane Roux
- Institut UTINAM, UMR6213 UFC-CNRS, Université de Franche-Comté, Besançon cedex, France
| | - Olivier Tillement
- Institut Lumière Matière, UMR5306 Université Lyon 1-CNRS, Université de Lyon, 69622 Villeurbanne cedex, France
| |
Collapse
|
27
|
Vincent Ching HY, Demay-Drouhard P, Bertrand HC, Policar C, Tabares LC, Un S. Nanometric distance measurements between Mn(ii)DOTA centers. Phys Chem Chem Phys 2015; 17:23368-77. [DOI: 10.1039/c5cp03487f] [Citation(s) in RCA: 18] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/11/2022]
Abstract
The distance between two Mn(ii)DOTA complexes attached to the ends of polyproline helices of varying lengths was measured by 94 GHz PELDOR spectroscopy with good accuracy demonstrating their effectiveness as spin-labels.
Collapse
Affiliation(s)
- H. Y. Vincent Ching
- Institute for Integrative Biology of the Cell (I2BC)
- Department of Biochemistry
- Biophysics and Structural Biology
- Université Paris-Saclay
- CEA
| | - Paul Demay-Drouhard
- Ecole Normale Supérieure-PSL Research University
- Départment de Chimie
- Sorbonne Universités – UPMC Univ Paris 06
- CNRS UMR 7203 LBM
- F-75005 Paris
| | - Hélène C. Bertrand
- Ecole Normale Supérieure-PSL Research University
- Départment de Chimie
- Sorbonne Universités – UPMC Univ Paris 06
- CNRS UMR 7203 LBM
- F-75005 Paris
| | - Clotilde Policar
- Ecole Normale Supérieure-PSL Research University
- Départment de Chimie
- Sorbonne Universités – UPMC Univ Paris 06
- CNRS UMR 7203 LBM
- F-75005 Paris
| | - Leandro C. Tabares
- Institute for Integrative Biology of the Cell (I2BC)
- Department of Biochemistry
- Biophysics and Structural Biology
- Université Paris-Saclay
- CEA
| | - Sun Un
- Institute for Integrative Biology of the Cell (I2BC)
- Department of Biochemistry
- Biophysics and Structural Biology
- Université Paris-Saclay
- CEA
| |
Collapse
|
28
|
Fenton JM, Busse M, Rendina LM. Synthesis and DNA-Binding Studies of a Dinuclear Gadolinium(III)–Platinum(II) Complex. Aust J Chem 2015. [DOI: 10.1071/ch14572] [Citation(s) in RCA: 6] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/23/2022]
Abstract
The synthesis and characterisation of a new dinuclear GdIII–PtII complex (1·PF6) containing a functionalised macrocyclic 1,4,7,10-tetraazacyclododecane-1,4,7-triacetic acid derivative linked to a PtII-terpy (terpy = 2,2′ : 6′,2″-terpyridine) unit by means of a short thiolato linker are reported. The complex was synthesised in six steps from cyclen by means of a modular synthetic strategy. A preliminary DNA-binding study with calf-thymus DNA (ct-DNA) was performed on 1·PF6 by means of linear dichroism (LD). The observed changes in the DNA LD signal in the presence of the metal complex are fully consistent with an intercalative binding mode. Furthermore, an induced negative LD signal in the ultraviolet absorption region of the complex provides strong evidence of a strong DNA-binding interaction. The in vitro cytotoxicity of 1·PF6 towards a human glioblastoma cell line (T98G) was also determined.
Collapse
|
29
|
Morrison DE, Aitken JB, de Jonge MD, Issa F, Harris HH, Rendina LM. Synthesis and Biological Evaluation of a Class of Mitochondrially-Targeted Gadolinium(III) Agents. Chemistry 2014; 20:16602-12. [DOI: 10.1002/chem.201404107] [Citation(s) in RCA: 18] [Impact Index Per Article: 1.8] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/24/2014] [Indexed: 11/10/2022]
|